Skip to content
Clinical Trials – home

MD Korczowski Bartosz Gabinet Lekarski

Verifiedinfo

Poland ul. Litewska 4A/7, 35-302 Rzeszow, Poland

  • 10 trials recruiting
  • Colitis ulcerative · Crohn's disease · Juvenile psoriatic arthritis
  • Adults and children

About Specializations

MD Korczowski Bartosz Gabinet Lekarski in Rzeszow, Poland specialises in clinical trials of conditions such as Colitis ulcerative, Crohn's disease, Juvenile psoriatic arthritis, Coeliac disease, and other specialisations. This site conducts important research.

Main research areas of the site

Digestive System Diseases

At MD Korczowski Bartosz Gabinet Lekarski in Rzeszow, much of the research focuses on digestive system diseases, especially inflammatory bowel disease such as Crohn’s disease and ulcerative colitis. These studies are designed to assess new and existing therapies, with attention to symptom control, remission, and long-term treatment benefit in pediatric patients.

  • Testing treatments for Crohn’s disease and ulcerative colitis in children and adolescents
  • Evaluating therapies for complex perianal fistulas and other difficult-to-manage bowel complications
  • Comparing treatment effectiveness for improving clinical remission and digestive health outcomes

The site is also involved in work on gastroesophageal reflux disease, erosive esophagitis, and related upper digestive conditions, broadening its pediatric gastroenterology research portfolio.

Immune System Diseases

Research in immune system diseases at this pediatric center includes studies in Crohn’s disease, ulcerative colitis, and juvenile psoriatic arthritis. The main goal is to better understand how immune-targeted treatments can reduce inflammation and support sustained disease control in young patients.

  • Studying immune-modulating therapies for pediatric inflammatory bowel disease
  • Assessing treatment benefit in juvenile psoriatic arthritis
  • Monitoring long-term safety and effectiveness of biologic therapies

These trials reflect a strong focus on immune-mediated conditions, with research aimed at improving everyday disease management and reducing the burden of chronic inflammation.

Nutritional and Metabolic Diseases

The site also supports studies in nutritional and metabolic diseases, including obesity or overweight and iron deficiency anemia. This work explores new ways to improve metabolic health and address common pediatric nutritional problems that can affect growth, energy, and overall well-being.

  • Evaluating approaches for iron deficiency anemia in children
  • Studying treatment strategies related to obesity and weight-related health concerns
  • Looking at supportive care for children at risk of nutritional deficiency

This area complements the gastroenterology focus by addressing conditions that often overlap with chronic digestive illness and pediatric health challenges.

Skin and Connective Tissue Diseases

Clinical research in skin and connective tissue diseases includes juvenile psoriatic arthritis, a condition that affects both the joints and the immune system. The studies aim to evaluate how well targeted treatments can improve symptoms, function, and long-term disease control in children.

  • Investigating therapies for juvenile psoriatic arthritis
  • Assessing disease control in inflammatory conditions affecting the skin and joints
  • Supporting research on pediatric autoimmune disease

This research adds an important rheumatologic dimension to the site’s pediatric clinical trial activity.

Immune System Processes

A further area of interest is immune system processes, where studies are examining how inflammation develops and how it can be controlled more effectively. At this site, that research is closely tied to chronic intestinal and autoimmune diseases in children.

  • Exploring inflammatory pathways involved in pediatric bowel disease
  • Supporting development of treatments that target immune-driven inflammation
  • Evaluating whether therapies can improve remission and reduce disease activity

Overall, the research profile at MD Korczowski Bartosz Gabinet Lekarski centers on helping children with chronic immune-related conditions through studies of treatment effectiveness, safety, and long-term disease management.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
ul. Litewska 4A/735-302 RzeszowPoland
Recruiting now
10 trials
Conditions studied
11
Partner status
Verified

More sites in RzeszowPoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

28 clinical trials

Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ro7790121
  • Sponsor:F. Hoffmann-La Roche AG

Coeliac disease

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Methyl (E,6S)-7-[[1-[2-(2-Ethylbutylamino)-2-Oxoethyl]-2-Oxopyridin-3-Yl]Amino]-6-[(3-Methylimidazole-4-Carbonyl)Amino]-7-Oxohept-2-Enoate
  • Sponsor:Dr. Falk Pharma GmbH
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Vedolizumab
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Prednisone
  • Sponsor:Takeda Development Center Americas Inc.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Ferumoxytol
  • Sponsor:Amag Pharmaceuticals Inc.
Countries:PolandPoland
  • Participants:0–17 years · 18–64 years
  • Substances:Guselkumab
  • Sponsor:Janssen Cilag International
Countries:PolandPoland
  • Participants:0–17 years
  • Substances:Filgotinib
  • Sponsor:Alfasigma S.p.A.
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziltivekimab
  • Sponsor:Novo Nordisk A/S
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.